Yazar "Yağcı, İlker" için Makale Koleksiyonu listeleme
-
Clinical performance of ASAS health index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: Real-world evidence from Multicenter Nationwide Registry
Akgül, Özgür; Bodur, Hatice; Ataman, Şebnem; Yurdakul, Fatma Gül; Çapkın, Erhan; Gürer, Gülcan; Sezer, İlhan; Duruöz, Mehmet Tuncay; Alkan Melikoğlu, Meltem; Çay, Hasan Fatih; Rezvani, Aylin; Yağcı, İlker; Göğüs, Feride; Kamanlı, Ayhan; Çevik, Remzi (Springer Heidelberg, 2020)The Assessment of SpondyloArthritis international Society Health Index (ASAS HI) is used as a new instrument in measuring the function, disability and health of patients with spondyloarthritis (SpA). However, the real-world ... -
Clinical performance of rheumatoid arthritis impact of disease score: A real-life evidence from the multicenter nationwide registry BioStaR
Alkan Melikoğlu, Meltem; Ataman, Şebnem; Bodur, Hatice; Çay, Hasan Fatih; Çapkın, Erhan; Akgül, Özgür; Çevik, Remzi; Göğüş, Feride; Kamanlı, Ayhan; Yurdakul, Fatma Gül; Gürer, Gülcan; Yağcı, İlker; Rezvani, Aylin; Duruöz, Mehmet Tuncay; Sunar, İsmihan (Springer Heidelberg, 2021)The rheumatoid arthritis impact of disease (RAID) score was developed as a patient-derived composite response index for the evaluation of the disease impact on cases with rheumatoid arthritis (RA). The aim of this study ... -
Demographic and clinical characteristics of patients with sustained and switching treatments using biological and targeted synthetic disease-modifying antirheumatic drugs: A multicenter, observational cross-sectional study for rheumatoid arthritis
Ataman, Şebnem; Sunar, İsmihan; Bodur, Hatice; Alkan Melikoğlu, Meltem; Çay, Hasan Fatih; Çapkın, Erhan; Akgül, Özgür; Çevik, Remzi; Göğüş, Feride; Kamanlı, Ayhan; Yurdakul, Fatma Gül; Gürer, Gülcan; Yağcı, İlker; Rezvani, Aylin; Duruöz, Mehmet Tuncay (Springer, 2022)Introduction Rheumatoid arthritis is a chronic inflammatory disease with different disease activity grades. Several registries have been designed to determine the appropriate regimens of disease-modifying antirheumatic ... -
Is the transcranial magnetic stimulation an adjunctive treatment in fibromyalgia patients?
Yağcı, İlker; Ağırman, Mehmet; Öztürk, Demet; Eren, Beyhan (AVES, 2014)Objective: To investigate the effectiveness of low-frequency (LF) repetitive transcranial magnetic stimulation (rTMS) to the motor cortex area in fibromyalgia patients who are resistant to medical treatment. Material and ... -
Is ultrasonography useful in the diagnosis of the polyneuropathy in diabetic patients?
Ağırman, Mehmet; Yağcı, İlker; Leblebicier Akdeniz, Merve; Öztürk, Demet; Akyüz, Gülseren Derya (Society of Physical Therapy Science (Rigaku Ryoho Kagakugakkai), 2016)[Purpose] The aim of this study was to investigate the usefulness of ultrasonography for the diagnosis of polyneuropathy in diabetic patients by examination of the median and ulnar nerves. [Subjects and Methods] Sixty-three ... -
The relationships of motor-evoked potentials to hand dexterity, motor function, and spasticity in chronic stroke patients: A transcranial magnetic stimulation study
Çakar, Engin; Akyüz, Gülseren; Durmuş, Oǧuz; Bayman, Levent; Yağcı, İlker; Karadağ Saygı, Evrim; Gündüz, Osman Hakan (Springer, 2016)The standardization of patient evaluation and monitoring methods has a special importance in evaluating the effectiveness of therapeutic methods using drugs or rehabilitative techniques in stroke rehabilitation. The aim ... -
Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: A real-life evidence from BioStaR nationwide registry
Bodur, Hatice; Yurdakul, Fatma Gül; Ataman, Şebnem; Çay, Hasan Fatih; Gürer, Gülcan; Çapkın, Erhan; Sezer, İlhan; Duruöz, Mehmet Tuncay; Alkan Melikoğlu, Meltem; Rezvani, Aylin; Yağcı, İlker; Göğüs, Feride; Kamanlı, Ayhan; Akgül, Özgür; Çevik, Remzi (Springer Science and Business Media Deutschland GmbH, 2022)Objectives Factors associated with disease activity of axial spondyloarthritis (axSpA) and switching of biologic disease-modifying anti-rheumatic drugs have not been clearly defined. We aimed to evaluate clinical characteristics ...